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Abstract
Introduction: It is unknown whether resources necessary to implement the Surviving Sepsis Campaign guidelines
and sepsis bundles are available in Africa. This self-reported, continent-wide survey compared the availability of
these resources between African and high-income countries, and between two African regions (Sub-Sahara Africa
vs. South Africa, Mauritius and the Northern African countries).
Methods: The study was conducted as an anonymous questionnaire-based, cross-sectional survey among
anaesthesia providers attending a transcontinental congress. Based on the respondents’ country of practice,
returned questionnaires were grouped into African and high-income countries. The questionnaire contained 74
items and evaluated all material resources required to implement the most recent Surviving Sepsis Campaign
guidelines. Group comparisons were performed with the Chi
2, Fisher’s Exact or Mann Whitney U test, as
appropriate.
Results: The overall response rate was 74.3% (318/428). Three-hundred-seven questionnaires were analysed (African
countries, n = 263; high-income countries, n = 44). Respondents from African hospitals were less likely to have an
emergency room (85.5 vs. 97.7%, P = 0.03) or intensive care unit (73.8 vs. 100%, P < 0.001) than respondents from
high-income countries. Drugs, equipment, and disposable materials required to implement the Surviving Sepsis
Campaign guidelines or sepsis bundles were less frequently available in African than high-income countries. Of all
African and Sub-Saharan African countries, 1.5% (4/263) and 1.2% (3/248) of respondents had the resources
available to implement the Surviving Sepsis Campaign guidelines in entirety. The percentage of implementable
recommendations was lower in African than in high-income countries (72.6 (57.7 to 87.7)% vs. 100 (100 to 100)%,
P < 0.001) and lower in Sub-Saharan African countries than South Africa, Mauritius, and the Northern African
countries (72.6 (56.2 to 86.3)% vs. 90.4 (71.2 to 94.5)%, P = 0.02).
Conclusions: The results of this self-reported survey strongly suggest that the most recent Surviving Sepsis
guidelines cannot be implemented in Africa, particularly not in Sub-Saharan Africa, due to a shortage of required
hospital facilities, equipment, drugs and disposable materials. However, availability of resources to implement the
majority of strong Surviving Sepsis Campaign recommendations and the sepsis bundles may allow modification of
current sepsis guidelines based on available resources and implementation of a substantial number of life-saving
interventions into sepsis care in Africa.
* Correspondence: Martin.Duenser@i-med.ac.at
† Contributed equally
8Department of Anaesthesiology, Perioperative and Intensive Care Medicine,
Salzburg General Hospital and Paracelsus Private Medical University, Müllner
Hauptstrasse 48, 5020 Salzburg, Austria
Full list of author information is available at the end of the article
Baelani et al. Critical Care 2011, 15:R10
http://ccforum.com/content/15/1/R10
© 2011 Baelani et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Introduction
The annual incidence of sepsis is 750,000 cases in the
United States and is increasing by 9% each year [1]. Sep-
sis is a major burden on the US healthcare system
resulting in annual costs of $16.7 billion [2]. In
Germany, an annual sepsis case load of 76 to 110 per
100,000 inhabitants has been estimated and held respon-
sible for approximately 60,000 deaths per year [3].
Despite these startling figures from high-income coun-
tries, the largest part of the global burden of sepsis still
occurs unrecognized by the Western medical commu-
nity. Given that approximately 80% of the world’s popu-
lation live in low- or middle-income countries [4], it can
be assumed that most sepsis cases occur outside the
more economically developed world. While few reports
on the outcome of sepsis in these countries exist, low
hygienic standards, widespread malnutrition and a high
incidence of bacterial, parasitic and HIV infection sug-
gest a disproportionally high morbidity and mortality
from sepsis in low- and middle-income countries [5].
Indeed, the latest global burden of disease report of the
World Health Organization found that three infectious
diseases (lower respiratory tract infection, diarrhoeal dis-
eases, HIV/AIDS) range among the four most frequent
causes of death in low-income countries [6].
During recent years, sepsis care in high-income coun-
tries has substantially improved due to extensive
research efforts allowing novel insights into the patho-
physiology and treatment of sepsis [7]. Current scientific
evidence to improve the care of severe sepsis or septic
s h o c kp a t i e n t si ss u m m a r i z e di nt h eS u r v i v i n gS e p s i s
Campaign (SSC) guidelines [8,9], which are considered
the gold standard of care in many countries. As repeat-
edly shown [10,11], implementation of the SSC guide-
lines into routine care can improve outcome from
severe sepsis and septic shock. However, the possibility
to implement the SSC guidelines in low- and middle-
income countries has been questioned [5,12,13].
The aim of this survey was to compare availability of
resources required to implement the SSC guidelines and
sepsis bundles between anaesthesia providers from
African and high-income countries as well as bet-
ween anaesthesia providers from two African regions
(Sub-Sahara Africa vs. South Africa, Mauritius and the
Northern African countries). Based on personal experience
and recent data, we hypothesized that the SSC guidelines
could not effectively be implemented by African anaesthe-
sia providers due to a lack of necessary hospital facilities,
equipment, drugs and disposable materials.
Materials and methods
This study was conducted as a self-reported, question-
naire-based, cross-sectional survey among anaesthesia
providers attending the 4
th All Africa Anaesthesia Con-
gress held in Nairobi/Kenya from 12 to 16 September
2009. During the opening plenary session of the con-
gress, all attendants were informed about the purpose
and anonymous design of the study together with the
fact that its results would be published in a scientific
journal. Considering that participation in the survey and
information disclosure were voluntary, the study proto-
col did not undergo review by an Ethics Committee.
Participants
O nt h ef i r s tt w od a y so ft h ec o n g r e s s ,q u e s t i o n n a i r e s
were haphazardly distributed to anaesthesia providers
(both physicians and non-physicians) attending the con-
gress. No incentives to complete the survey were
offered. Throughout the congress, seven investigators
were on site to collect the completed questionnaire
responses and to be available for assistance in complet-
ing the form. Questionnaires retrieved from respondents
practicing in an African (Table S1 in Additional file 1)
or high-income country were eligible for study inclusion.
High-income countries were defined according to the
latest World Bank report [4]. Questionnaires completed
by non-healthcare providers or those from non-African
low- or middle-income countries were excluded.
Survey instrument and data collection
The questionnaire was designed by all investigators
based on the latest SSC guidelines. It was anonymous,
contained 74 items grouped into seven main categories
(general information, hospital facilities, drugs, patient
monitoring, laboratory, equipment, disposables) and can
be downloaded from the Additional file 1. Responses
were classified as ‘yes’, ‘no’, ‘don’t know’ for the category
‘hospital facilities’,a n d‘always’, ‘sometimes’, ‘never’,
‘don’tk n o w ’ for the remaining categories. The ‘general
information’ category optionally required two open-
ended text responses (’other hospital type’ and ‘other
medical grade’) which were retrospectively coded by two
study investigators. The study questionnaire was written
in English, underwent pre-testing by the investigators
and subsequently pilot testing by 10 anaesthesia provi-
ders in two African countries (Hospital of Kisumu/
Kenya, n = 5; Muhimbili Hospital, Dar-Es-Salaam/
Tanzania, n = 5). For the pilot test, anaesthesia provi-
ders were asked to complete and examine the question-
naire with regard to its flow, salience, acceptability and
administrative ease. Inter-rater reliability was assessed
for all five respondents from each hospital and yielded a
Cohen’s Kappa of 0.71. Based on the results of the pilot
testing and individual feedback, the questionnaire was
modified. Finally, it was again reviewed and approved by
all investigators.
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The main study variable was availability of resources
necessary to implement the latest SSC guidelines and
their sepsis resuscitation/management bundles [9]. Prior
to the survey, hospital facilities, equipment, drugs and
disposable materials required to implement individual
SSC recommendations and sepsis bundles were defined
by consensus of the investigators (Table S2 in Addi-
tional file 1). In order to consistently implement the
SSC guidelines, resources had to be ‘always’ available.
Resources ‘sometimes’ or ‘never’ available, as well as
those respondents who did not know whether they were
available at their hospital were considered insufficient
to implement the SSC guidelines. Furthermore, the
percentage of implementable recommendations of
the SSC guidelines was calculated for each returned
questionnaire.
Study cohorts and survey goals
Based on the respondents’ countries of practice, ques-
tionnaires were grouped into African and high-income
countries. Furthermore, African countries were sub-
grouped into two regions: 1) Sub-Saharan African coun-
tries generally representing low-income countries, and
2) South Africa, Mauritius, and the Northern African
countries rated as middle-income countries according to
the World Bank [4]. With few exceptions, this econ-
omy-based country classification by the World Bank
correlates well with the quality and development of the
national health care systems [4].
The primary goal of our survey was to compare the
availability of each resource to implement the SSC
guidelines, the percentage of implementable guidelines,
and the possibility to implement the SSC guidelines
(Grade 1 and 2 recommendations) and their associated
sepsis bundles (resuscitation and management bundles)
between respondents and hospitals from African and
high-income countries. Comparison of the same vari-
ables between respondents from Sub-Saharan African
countries and South Africa, Mauritius, and the Nor-
thern African countries was considered the secondary
survey goal.
Data processing and statistical analysis
Questionnaires were manually entered into a centralized
database. After random cross-checking, the database was
re-checked by calculating minimum and maximum
values of each question in order to detect entry errors.
The SPSS software package (SPSS 13.0.1; SPSS Inc.,
Chicago, IL, USA) was used for statistical analysis. Fre-
quencies based on the number of completed questions
(some questions were not completed by all respondents)
were calculated for all categorical data. Continuous vari-
ables are presented as median values with interquartile
ranges. Categorical and non-continuous variables were
compared between groups using the Chi
2-o rF i s h e r ’s
Exact test, as appropriate. For comparisons of resource
availability, only ‘always’, ‘sometimes’ and ‘never’ choices
were statistically evaluated. Group comparisons of con-
tinuous data were performed with the Mann Whitney U
test. P-values < 0.05 were considered to indicate statisti-
cal significance.
Results
Questionnaires were randomly distributed to 428 of 832
congress attendants. A total of 318 questionnaires were
returned (overall response rate, 74.3%). Eleven question-
naires had to be excluded because respondents practi-
cing in non-African middle-income countries (India, n =
5; Romania, n = 2), were returned blank (n =3 ) ,o r
were completed by non-healthcare providers (n =1 ) .
Finally, 307 questionnaires were statistically analysed
(African countries, n = 263; high-income countries, n =
44). Respondents from 185 hospitals located in 14 high-
income and 24 African countries (45.3% of all 53 Afri-
can countries) were included (Sub-Saharan African
countries, n = 248; South Africa, Mauritius, and the
Northern African countries, n = 15) (Figure 1). The
median (interquartile range) number of respondents per
hospital, respondents per country, and respondents’ hos-
pitals per country was 1 (1 to 1), 2 (1 to 5), and 2 (1 to
4), respectively. One hundred-nine questionnaires
(35.5%) were partially incomplete. The median number
of missing responses per incomplete questionnaire was
1 (interquartile range, 1 to 3).
Characteristics of respondents and their hospitals are
summarized in Table 1. Significant differences between
respondents from African and high-income countries
were observed in regards to the respondent’s specialty,
hospital type and size, as well as the availability of an
emergency room and an intensive care unit. Differences
in the availability of an intensive care unit were
observed between Sub-Saharan African countries and
South Africa, Mauritius, and the Northern African
countries (Table S3 in Additional file 1).
Respondents from African countries reported to have
drugs (Table 2), equipment (Table 3), and disposable
materials (Table 4) required to implement the SSC
guidelines less frequently available than respondents
from high-income countries. Certain drugs, equipment,
and disposable materials (Table S4-6 in Additional file
1) were less frequently available for respondents from
Sub-Saharan African countries compared to those from
South Africa, Mauritius, and the Northern African
countries. The possibility to perform thick drop analysis
to diagnose malaria was the single resource more fre-
quently available for respondents from African countries
compared to high-income countries and for respondents
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Africa, Mauritius, and the Northern African countries.
Of all African respondents and hospitals, four (1.5%)
and two (1.4%), respectively, stated to have the resources
available to consistently implement the SSC guidelines
or any of their sepsis resuscitation and management
bundles (Tables 5 and 6). Respondents and hospitals
from African countries less frequently had all resources
available to implement the SSC guidelines (Grade 1 and
2 recommendations) than respondents from high-
High-income countries (n=44)
￿ Australia 
￿ Austria 
￿ Belgium 
￿ Canada 
￿ France 
￿ Germany 
￿ Ireland 
￿ Netherlands 
￿ New Zealand 
￿ Norway 
￿ Sweden 
￿ Switzerland 
￿ United Kingdom 
￿ United States of America 
African countries (n=263) 
Figure 1 Countries of practice of survey participants. Sub-Saharan African countries (n = 248) are marked in dark grey. South Africa,
Mauritius and the Northern African countries (n = 15) are marked in light grey.
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grade 1 and 2 recommendations was lower in respon-
dents and hospitals from African compared to high-
income countries (Tables 5 and 6). The percentage of
implementable SSC guidelines was different between
African respondents working in hospital of different
types (<0.01 for all comparisons; data not shown).
Resources to implement the SSC guidelines (grade 1
and 2 recommendations) tended to be less frequently
available for respondents from Sub-Saharan African
countries than those from South Africa, Mauritius, and
the Northern African countries (Table 7).
Discussion
The results of this continent-wide, cross-sectional, self-
reported, questionnaire-based survey indicate that while
almost all respondents from high-income countries
reported to be able to implement the latest SSC guide-
lines, only a small percentage of African respondents
stated to have the required facilities, equipment, drugs
and disposable materials consistently available to imple-
ment the SSC in entirety. These results remained
unchanged when comparisons were made between hos-
pitals instead of respondents. Supporting our hypothesis,
these data imply that the SSC guidelines cannot be
implemented in entirety by African, particularly not by
Sub-Saharan African, respondents due to a lack of
necessary resources. However, with a wide variability
among African respondents, resources appear to be
available to implement approximately three-quarter of
individual SSC recommendations. These results are
important for the future management of sepsis care in
Africa.
The finding that only 1.5% of African respondents and
even less from Sub-Sahara Africa (1.2%) reported to
have the resources constantly available to treat sepsis
patients according to the latest SSC guidelines in
entirety is striking on the first sight. However, almost
three-quarters of individual SSC recommendations and
sepsis resuscitation/management bundles could be
implemented by African respondents. The interquartile
range of implementable guidelines (57.5 to 87.7%) was
wide, suggesting considerable heterogeneity among
respondents. When interpreting these figures, it needs
to be taken into account that 16 of the 73 (21.9%)
recommendations of the SSC guidelines are either pas-
sive (’do not use’)o rr e q u i r en or e s o u r c e sa ta l l .T h e s e
results underline earlier criticism that SSC guidelines
may not be feasible in low- or middle-income countries
[5,12,13]. Our finding that not even all respondents of
high-income countries reported to have resources avail-
able to implement the SSC guidelines was unexpected.
However, this was due to the lack of selected resources
(for example, vasopressin or activated protein C). The
median percentage of implementable SSC recommenda-
tions reported by respondents from high-income coun-
tries was 100%.
Lack of resources required to implement the SSC
guidelines and sepsis bundles by African anaesthesia
providers was not confined to specific materials but
Table 1 Characteristics of respondents and their hospitals
African countries High-income countries P-value
n 263 44
Specialty of respondent n (%) 0.002*
Physician anaesthetist 150 (57) 35 (81.8)
Non-physician anaesthetist 92 (35) 5 (11.4)
Other physician 6 (2.3) 3 (6.8)
Other 15 (5.7) 0
Type of hospital n (%) 0.01*
University teaching 117 (44.5) 19 (43.2)
Regional/Provincial 30 (11.4) 11 (25)
District 34 (12.9) 9 (20.5)
Private 61 (23.2) 3 (6.8)
Other 21 (8) 2 (4.6)
Size of hospital (beds) 350 (200 to 1,000) 600 (388 to 800) 0.03*
Availability of hospital facilities n (%)
Emergency room 225 (85.6) 43 (97.7) 0.03*
Operation theatre 260 (98.9) 44 (100) 1
Intensive care unit 194 (73.8) 44 (100) <0.001*
*, significant group difference.
Data are given as median values with interquartile ranges, if not otherwise indicated.
Comparisons were made with a Fisher’s Exact or a Mann Whitney U test (size of hospital).
Baelani et al. Critical Care 2011, 15:R10
http://ccforum.com/content/15/1/R10
Page 5 of 12appears multi-faceted. For example, 25% of respondents
stated that their hospital did not have an intensive care
unit. Similarly, an emergency room, a key hospital facil-
ity to timely recognize, triage and treat sepsis patients
[14,15], was not available in the hospitals of 15% of
respondents. Nearly all materials necessary to imple-
ment the SSC guidelines were less frequently available
for African respondents compared to those from high-
income countries. Particularly shocking is the inconsis-
tent supply or lack of basic resources such as oxygen,
fluids and broad-spectrum antibiotics or essential
disposables and monitoring equipment reported by
some respondents. As suggested before [16,17], the lack
of resources was especially pronounced for respondents
practicing in Sub-Sahara Africa.
Although our survey did not specifically ask whether
respondents routinely care for sepsis patients, several
earlier studies reported that anaesthetists are crucially
involved in intensive care medicine and in the care of
critically ill sepsis patients in Africa [16,18-22]. None-
theless, it is notable that a relevant number of respon-
dents stated that they did not know whether certain
Table 2 Availability of drugs to implement the surviving sepsis campaign guidelines
African countries
N = 263
High-income countries
N =4 4
P-value
Always Some-times Never Don’t know Always Some-times Never Don’t know
Oxygen 243 (93.8) 15 (5.8) 1 (0.4) 0 44 (100) 0 0 0 0.24
Antibiotics
Ampicilline 201 (78.5) 47 (18.4) 5 (2) 3 (1.2) 44 (100) 0 0 0 0.004*
Gentamycine 243 (92.4) 19 (7.2) 0 1 (0.4) 44 (100) 0 0 0 0.07
3
rd/4
th Gen Cephalosporine 203 (77.5) 57 (21.8) 1 (0.4) 1 (0.4) 44 (100) 0 0 0 0.002*
Piperacilline 65 (26.4) 40 (16.3) 83 (33.7) 58 (23.6) 43 (97.7) 0 0 1 (2.3) <0.001*
Carbapenem 79 (32.1) 46 (18.7) 68 (27.6) 53 (21.5) 43 (97.7) 0 0 1 (2.3) <0.001*
IV fluids
Crystalloids 254 (96.6) 9 (3.4) 0 0 44 (100) 0 0 0 0.21
Colloids 158 (60.8) 81 (31.2) 16 (6.2) 5 (1.9) 44 (100) 0 0 0 <0.001*
Blood products
Red blood cells 206 (79.5) 51 (19.7) 1 (0.4) 1 (0.4) 44 (100) 0 0 0 0.005*
Fresh frozen plasma 109 (42.6) 81 (31.6) 59 (23) 7 (2.7) 44 (100) 0 0 0 <0.001*
Platelets 69 (27.2) 93 (36.6) 79 (31.1) 13 (5.1) 44 (100) 0 0 0 <0.001*
Cardiovascular drugs
Noradrenaline 119 (46.7) 60 (23.5) 67 (26.3) 9 (3.5) 44 (100) 0 0 0 <0.001*
Dopamine 133 (51.4) 68 (26.3) 52 (20.1) 6 (2.3) 44 (100) 0 0 0 <0.001*
Dobutamine 94 (37.2) 67 (26.5) 77 (30.4) 15 (5.9) 44 (100) 0 0 0 <0.001*
Adrenaline 255 (97.3) 7 (2.7) 0 0 44 (100) 0 0 0 0.27
Hydrocortisone 252 (96.2) 9 (3.4) 0 1 (0.4) 44 (100) 0 0 0 0.21
Vasopressin 76 (29.8) 66 (25.9) 93 (36.5) 20 (7.8) 43 (97.7) 0 0 1 (2.3) <0.001*
Anesthetic/sedative drugs
Thiopentone 243 (93.1) 11 (4.2) 7 (2.7) 0 43 (97.7) 1 (2.3) 0 0 0.44
Propofol 154 (59) 71 (27.2) 36 (13.8) 0 43 (97.7) 1 (2.3) 0 0 <0.001*
Succinylcholine 242 (93.4) 9 (3.5) 7 (2.7) 1 (0.4) 44 (100) 0 0 0 0.24
ND Muscle Relaxant 185 (70.6) 59 (22.5) 18 (6.9) 0 44 (100) 0 0 0 <0.001*
IV opiate/opioide 208 (79.7) 50 (19.2) 3 (1.1) 0 44 (100) 0 0 0 0.004*
Diazepam 251 (95.8) 11 (4.2) 0 0 44 (100) 0 0 0 0.17
Midazolam 138 (52.9) 72 (27.6) 48 (18.4) 3 (1.1) 44 (100) 0 0 0 <0.001*
Others
Insulin 232 (89.2) 27 (10.4) 1 (0.4) 0 44 (100) 0 0 0 0.07
Heparin or LMWH 174 (67.7) 56 (21.8) 21 (8.2) 6 (2.3) 44 (100) 0 0 0 <0.001*
H2-Blockers 182 (70.3) 64 (24.7) 9 (3.5) 4 (1.5) 44 (100) 0 0 0 <0.001*
Proton pump inhibitor 145 (55.1) 82 (31.2) 18 (7.1) 10 (3.9) 42 (95.5) 0 0 2 (4.5) <0.001*
Activated protein C 15 (6.1) 32 (13) 139 (56.3) 61 (24.7) 39 (88.6) 1 (2.3) 2 (4.5) 2 (4.5) <0.001*
*, significant group difference (’don’t know’ choices were not included in statistical comparisons); H2, histamine receptor 2; IV, intravenous; LMWH, low molecular
weight heparin; ND, non-depolarizing.
All data are given as absolute values and percentages of completed responses.
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African countries
N = 263
High-income countries
N =4 4
P-value
Always Some-times Never Don’t know Always Some-times Never Don’t know
Diagnostic equipment
X-ray 236 (90.8) 14 (5.4) 10 (3.8) 0 44 (100) 0 0 0 0.11
Sonography 216 (83.4) 17 (6.6) 25 (9.7) 1 (0.4) 43 (97.7) 1 (2.3) 0 0 0.04*
Echocardiography 152 (60.6) 30 (12) 61 (24.3) 8 (3.2) 40 (90.9) 4 (9.1) 0 0 <0.001*
Laboratory investigations
Thick drop 251 (96.5) 4 (1.5) 3 (1.2) 2 (0.8) 35 (79.5) 3 (6.8) 5 (11.4) 1 (2.3) <0.001*
Gram stain 238 (92.2) 18 (7) 2 (0.8) 0 43 (97.7) 1 (2.3) 0 0 0.41
Microbiological cultures 193 (75.1) 44 (17.1) 19 (7.4) 1 (0.4) 44 (100) 0 0 0 0.001*
Antibiogram 181 (70.4) 51 (19.8) 21 (8.2) 4 (1.6) 44 (100) 0 0 0 <0.001*
Blood sugar 242 (93.1) 17 (6.5) 1 (0.4) 0 44 (100) 0 0 0 0.2
Blood gas analysis 110 (43.5) 48 (19) 89 (35.2) 6 (2.4) 44 (100) 0 0 0 <0.001*
Lactate 64 (25.7) 60 (24.1) 92 (36.9) 33 (13.3) 43 (97.7) 1 (2.3) 0 0 <0.001*
Blood count 227 (87.6) 27 (10.4) 4 (1.5) 1 (0.4) 44 (100) 0 0 0 0.05
Creatinine 201 (78.2) 40 (15.6) 15 (5.8) 1 (0.4) 44 (100) 0 0 0 0.003*
Bilirubin 194 (74.6) 46 (17.7) 18 (6.9) 2 (0.8) 44 (100) 0 0 0 0.001*
Prothrombin time/INR 176 (68.5) 39 (15.2) 36 (14) 6 (2.3) 44 (100) 0 0 0 <0.001*
Other coagulation tests 149 (60.1) 59 (23.8) 29 (11.7) 11 (4.4) 44 (100) 0 0 0 <0.001*
Monitoring equipment
Body temperature 205 (79.2) 50 (19.3) 2 (0.8) 2 (0.8) 42 (95.5) 2 (4.5) 0 0 0.04*
Non-invasive blood pressure 241 (93.8) 11 (4.3) 5 (1.9) 0 43 (97.7) 1 (2.3) 0 0 0.52
Invasive blood pressure 58 (23.1) 84 (33.5) 102 (40.6) 7 (2.8) 41 (93.2) 3 (6.8) 0 0 <0.001*
Oxygen saturation 199 (76.8) 42 (16.2) 18 (6.9) 0 44 (100) 0 0 0 <0.001*
Central venous pressure 87 (33.9) 78 (30.4) 90 (35) 2 (0.8) 41 (93.2) 3 (6.8) 0 0 <0.001*
Cardiac output 30 (12) 62 (24.8) 146 (58.4) 12 (4.8) 37 (84.1) 5 (11.4) 2 (4.5) 0 <0.001*
Pulmonary arterial pressure 22 (8.6) 45 (17.6) 174 (68) 15 (5.9) 34 (77.3) 8 (18.2) 2 (4.5) 0 <0.001*
Endtidal carbon dioxyde 99 (38.2) 78 (30.1) 78 (30.1) 4 (1.5) 43 (97.7) 1 (2.3) 0 0 <0.001*
Other equipment
Mechanical ventilator 184 (71.9) 38 (14.8) 34 (13.3) 34 (13.3) 44 (100) 0 0 0 <0.001*
Syringe pump 138 (53.9) 53 (20.7) 61 (23.8) 4 (1.6) 44 (100) 0 0 0 <0.001*
Fluid infuser 126 (49) 61 (23.7) 67 (26.1) 3 (1.2) 44 (100) 0 0 0 <0.001*
Peritoneal dialysis 91 (36) 50 (19.8) 98 (38.7) 14 (5.5) 38 (86.4) 3 (6.8) 1 (2.3) 2 (4.5) <0.001*
Hemodialysis/Hemofiltration 111 (43.2) 26 (10.1) 110 (42.8) 10 (3.9) 43 (97.7) 1 (2.3) 0 0 <0.001*
*, significant group difference (’don’t know’ choices were not included in statistical comparisons); INR, international normalized ratio; All data are given as
absolute values and percentages of completed responses.
Table 4 Availability of disposable material to implement the surviving sepsis campaign guidelines
African countries
N = 263
High-income countries
N =4 4
P-value
Always Some-times Never Don’t know Always Some-times Never Don’t know
Disposable material
IV cannula 253 (97.3) 6 (2.3) 1 (0.4) 0 44 (100) 0 0 0 0.55
IV fluid giving set 253 (97.7) 3 (1.2) 3 (1.2) 0 44 (100) 0 0 0 0.6
Urinary catheter 249 (95.4) 12 (4.6) 0 0 44 (100) 0 0 0 0.15
Nasogastric tube 246 (94.3) 15 (5.7) 0 0 44 (100) 0 0 0 0.1
Endotracheal tube 251 (96.5) 6 (2.3) 3 (1.2) 0 44 (100) 0 0 0 0.46
Oxygen face mask 252 (96.6) 7 (2.7) 2 (0.8) 0 44 (100) 0 0 0 0.46
Oxygen nasal cannula 212 (81.5) 37 (14.2) 9 (3.5) 2 (0.8) 44 (100) 0 0 0 0.01*
Central venous catheter 126 (48.8) 64 (24.8) 63 (24.4) 5 (1.9) 44 (100) 0 0 0 <0.001*
Antithrombotic stockings 65 (25.4) 64 (25) 94 (36.7) 33 (12.9) 43 (97.7) 1 (2.3) 0 0 <0.001*
*, significant group difference (’don’t know’ choices were not included in statistical comparisons); IV, intravenous.
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Page 7 of 12resources to treat sepsis were available at their hospital.
Given the drastic shortage of intensive care capacities in
some African countries such as in Zambia [16], it must
be assumed that many clinicians from other medical spe-
cialties routinely care for critically ill sepsis patients, for
example, on normal hospital wards. Considering this, our
survey only reflects the possibility of African anaesthesia
providers to implement the SSC guidelines and cannot
yield data on resource availability of other African health
care workers to care for sepsis patients. Furthermore, the
study specifically assessed the availability of resources
required to implement the SSC guidelines and did not
appraise the process of clinical sepsis care itself. It
remains unknown whether the scarce resources are used
appropriately. Similarly, our survey only evaluated the
qualitative availability of resources. Although some
resources may be available their quantity could still not
be adequate to treat all patients with sepsis.
The wide-ranging lack of resources as reflected by our
study entails that several potentially life-saving interven-
tions cannot be applied to sepsis patients in Africa.
Although no causative relationship can be drawn, high
sepsis mortality as reported from low- or middle-income
countries may be due to a lack of hospital facilities,
equipment, drugs and disposable materials. Accordingly,
a Tunisian study including 100 septic shock patients
reported a lethality of 82% [23]. Similarly, mortality
from severe sepsis was 80 and 92% in a tertiary centre
in Pakistan [24] and Turkey [25], respectively. Cheng
et al. observed a mortality of 90% in patients with
severe sepsis due to melioidosis in a Thai provincial
hospital [26].
Our survey has important limitations. First, although
the questionnaire used in this survey underwent pilot
testing, no assessment of test-retest reliability was per-
formed. Together with the lack of clinical sensibility
testing of the questionnaire, this limits the validity of
the results [27]. Second, by including only anaesthesia
providers attending a continent-wide congress our sur-
vey most likely experienced a relevant selection bias due
to respondent clustering. Accordingly, the proportion of
African respondents working either at university or
Table 5 Possibility to implement the surviving sepsis campaign guidelines
African countries High-income countries P-value
Respondents n 263 44
Possibility to implement the SSC guidelines in entirety n (%) 4 (1.5) 36 (81.8) <0.001*
Percentage of implementable recommendations/suggestions (%) 72.6 (57.5 to 87.7) 100 (100 to 100) <0.001*
Possibility to implement all Grade 1 recommendations n (%) 15 (5.7) 40 (90.9) <0.001*
Percentage of implementable Grade 1 recommendations (%) 80.8 (63.5 to 88.5) 100 (100 to 100) <0.001*
Possibility to implement all Grade 1A and 1B recommendations n (%) 30 (11.4) 41 (93.2) <0.001*
Percentage of implementable Grade 1A and 1B recommendations (%) 87.5 (70.8 to 95.8) 100 (100 to 100) <0.001*
Possibility to implement all Grade 1C and 1D recommendations n (%) 26 (9.9) 40 (90.9) <0.001*
Percentage of implementable Grade 1C and 1D recommendations (%) 71.4 (57.1 to 89.3) 100 (100 to 100) <0.001*
Possibility to implement all Grade 2 recommendations n (%) 4 (1.5) 36 (81.8) <0.001*
Percentage of implementable Grade 2 recommendations (%) 57.1 (38.1 to 81) 100 (100 to 100) <0.001*
Possibility to implement all sepsis resuscitation bundles n (%) 43 (16.3) 41 (93.2) <0.001*
Bundle element “Lactate” n (%) 64 (24.3) 43 (97.7) <0.001*
Bundle element “Cultures” n (%) 188 (71.5) 44 (100) <0.001*
Bundle element “Antibiotics” n (%) 204 (77.6) 44 (100) <0.001*
Bundle element “Hypotension” n (%) 238 (90.5) 44 (100) 0.03*
Bundle element “CVP/ScvO2” n (%) 70 (26.6) 41 (93.2) <0.001*
Possibility to implement all sepsis management bundles n (%) 12 (4.6) 39 (88.6) <0.001*
Bundle element “Steroids” n (%) 252 (95.8) 44 (100) 0.17
Bundle element “rhAPC” n (%) 15 (5.7) 39 (88.6) <0.001*
Bundle element “Glucose” n (%) 221 (84) 44 (100) 0.004*
Bundle element “Plateau Pressure” n (%) 182 (69.2) 44 (100) <0.001*
SSC, Surviving Sepsis Campaign; *, significant group difference. Data are given as median values with interquartile ranges, if not otherwise indicated. The
Surviving Sepsis Campaign categorized their recommendations using the GRADE system which classifies recommendations as strong (grade 1) or weak (grade 2).
Furthermore, the system Classifies the quality of evidence as high (grade A), moderate (grade B), low (grade C), or very low (grade D).The grade of strong or
weak is considered of greater clinical importance than a difference in letter level of quality of evidence. Sepsis Resuscitation Bundles: Element “Lactate”,
measurement of serum lactate; Element “Cultures”, obtainment of blood cultures prior to antibiotic administration; Element “Antibiotics”, administration of broad-
spectrum antibiotics within three hours of emergency department admission and within one hour of non-emergency department admission; Element
“Hypotension”, treatment of hypo-tension and/or elevated lactate with fluids; Element “CVP/ScvO2”, maintenance of adequate central venous pressure and
central venous oxygen saturation. Sepsis Management Bundles: Element “Steroids”, administration of low-dose steroids for septic shock in accordance with a
standardized ICU policy; Element “rhAPC”, administration of recombinant human activated protein C in accordance with a standardized ICU policy; Element
“Glucose”, maintenance of blood glucose control lower limit of normal, but <180 mg/dL (10 mmol/L); Element “Plateau Pressure”, maintenance of a median
inspiratory plateau pressure <30 cmH2O for mechanically ventilated patients.
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Page 8 of 12private hospitals was high, while barely 25% came from
provincial or district hospitals which make up the cru-
cial part of healthcare services in Africa. Some rural
African hospitals do not even have anaesthesia providers
available [28]. Therefore, our results almost certainly
overestimate the true situation of resource availability to
treat sepsis in Africa, particularly in rural hospitals.
Recent studies from Uganda [17] and Zambia [16]
reported a much lower availability of basic monitoring
devices or equipment than observed in our survey.
Third, the present survey only evaluated the availability
of material resources and not healthcare workers. Short-
age of sufficiently trained healthcare providers is another
threat to adequate patient care in Africa [28-30]. Even in
high-income countries, barriers to implementation of
the SSC guidelines may be related to inadequate staffing
[31]. Fourth, although our survey included respondents
from half of African countries, its results must not be
extrapolated to all of Africa. Additionally, the question-
naire did not assess the availability of resources
necessary to manage children with sepsis. Since special-
sized disposable materials and equipment are required,
it is likely that resources necessary to care for critically
ill children with sepsis are even less frequently available.
Finally, we cannot exclude that some respondents may
have misunderstood certain questions despite the avail-
ability of ‘don’tk n o w ’ choices. Although the congress
was held in English, it is possible that language pro-
blems contributed to misunderstandings. Some respon-
dents chose to answer only questions they could
respond with ‘yes’ or ‘always’ leaving the remaining
questions blank.
Several possibilities exist to improve sepsis care in
Africa. While a consistent supply of resources to imple-
ment the SSC guidelines in its entirety would not only
be logistically and economically unrealistic but also
require training of health care providers to use so far
unavailable resources, modification of existing sepsis
guidelines could help see that currently available
resources are used according to the latest clinical
Table 6 Possibility to implement the surviving sepsis campaign guidelines per hospital
African countries High-income countries P-value
Hospital n 143 42
Possibility to implement the ssc guidelines in entirety n (%) 2 (1.4) 34 (81) <0.001*
Percentage of implementable recommendations/suggestions (%) 67.1 (52.1 to 80.8) 100 (100 to 100) <0.001*
Possibility to implement all Grade 1 recommendations n (%) 5 (3.5) 38 (90.5) <0.001*
Percentage of implementable Grade 1 recommendations (%) 75 (59.6 to 84.6) 100 (100 to 100) <0.001*
Possibility to implement all Grade 1A and 1B recommendations n (%) 16 (11.2) 39 (92.9) <0.001*
Percentage of implementable Grade 1A and 1B recommendations (%) 83.3 (66.7 to 91.7) 100 (100 to 100) <0.001*
Possibility to implement all Grade 1C and 1D recommendations n (%) 9 (6.3) 38 (90.5) <0.001*
Percentage of implementable Grade 1C and 1D recommendations (%) 71.4 (57.1 to 82.1) 100 (100 to 100) <0.001*
Possibility to implement all Grade 2 recommendations n (%) 2 (1.4) 34 (81) <0.001*
Percentage of implementable Grade 2 recommendations (%) 47.6 (33.3 to 71.4) 100 (100 to 100) <0.001*
Possibility to implement all sepsis resuscitation bundles n (%) 14 (9.8) 39 (92.9) <0.001*
Bundle element “Lactate” n (%) 31 (21.7) 41 (97.6) <0.001*
Bundle element “Cultures” n (%) 97 (67.8) 42 (100) <0.001*
Bundle element “Antibiotics” n (%) 36 (25.2) 42 (100) <0.001*
Bundle element “Hypotension” n (%) 129 (90.2) 42 (100) 0.04*
Bundle element “CVP/ScvO2” n (%) 28 (19.6) 39 (92.9) <0.001*
Possibility to implement all sepsis management bundles n (%) 3 (2.1) 37 (88.9) <0.001*
Bundle element “Steroids” n (%) 137 (95.8) 42 (100) 0.18
Bundle element “rhAPC” n (%) 5 (3.5) 37 (88.9) <0.001*
Bundle element “Glucose” n (%) 115 (80.4) 42 (100) 0.002*
Bundle element “Plateau Pressure” n (%) 85 (59.4) 42 (100) <0.001*
SSC, Surviving Sepsis Campaign; *, significant group difference. Data are given as median values with interquartile ranges, if not otherwise indicated. The
Surviving Sepsis Campaign categorized their recommendations using the GRADE system which classifies recommendations as strong (grade 1) or weak (grade 2).
Furthermore, the system Classifies the quality of evidence as high (grade A), moderate (grade B), low (grade C), or very low (grade D).The grade of strong or
weak is considered of greater clinical importance than a difference in letter level of quality of evidence. Sepsis Resuscitation Bundles: Element “Lactate”,
measurement of serum lactate; Element “Cultures”, obtainment of blood cultures prior to antibiotic administration; Element “Antibiotics”, administration of broad-
spectrum antibiotics within three hours of emergency department admission and within one hour of non-emergency department admission; Element
“Hypotension”, treatment of hypo-tension and/or elevated lactate with fluids; Element “CVP/ScvO2”, maintenance of adequate central venous pressure and
central venous oxygen saturation. Sepsis Management Bundles: Element “Steroids”, administration of low-dose steroids for septic shock in accordance with a
standardized ICU policy; Element “rhAPC”, administration of recombinant human activated protein C in accordance with a standardized ICU policy; Element
“Glucose”, maintenance of blood glucose control lower limit of normal, but <180 mg/dL (10 mmol/L); Element “Plateau Pressure”, maintenance of a median
inspiratory plateau pressure <30 cmH2O for mechanically ventilated patients.
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Page 9 of 12evidence. This may be particularly relevant for therapeu-
tic interventions with a high chance of improving
patient survival. Optimistically, respondents reported to
have resources constantly available to implement up to
80% of grade 1A and 1B recommendations as well as
sepsis bundles suggesting that guideline modification
based on available resources may allow implementation
of a substantial number of life-saving interventions.
However, considering the wide variability of resource
availability observed and the regional shortage of essen-
tial resources, basic resources need to be supplied to
health care facilities to improve sepsis management.
Furthermore, establishment of emergency and intensive
care departments, adequate staffing and training of
health care providers could be further options to
improve the care of African patients suffering from
severe infection.
Conclusions
The results of this self-reported survey strongly suggest
that the most recent SSC guidelines cannot be implemen-
ted in Africa, particularly not in Sub-Sahara Africa, due to
a shortage of required hospital facilities, equipment, drugs
and disposable materials. However, availability of resources
to implement the majority of strong SSC recommendations
(grade 1a and 1b) and the sepsis bundles may allow modifi-
cation of current sepsis guidelines based on available
resources and implementation of a substantial number of
life-saving interventions into sepsis care in Africa.
Key messages
￿ Only a small percentage of African respondents sta-
ted that they have the required facilities, equipment,
drugs and disposable materials available to implement
the Surviving Sepsis Campaign guidelines.
Table 7 Possibility to implement the surviving sepsis campaign guidelines in African countries
Sub-Saharan African
countries
South Africa/
Mauritius/Northern
African countries
P-value
Respondents n 248 15
Possibility to implement the SSC guidelines in entirety n (%) 3 (1.2) 1 (6.7) 0.09
Percentage of implementable recommendations/suggestions (%) 72.6 (56.2 to 86.3) 90.4 (71.2 to 94.5 0.02*
Possibility to implement all Grade 1 recommendations n (%) 12 (4.8) 3 (20) 0.01*
Percentage of implementable Grade 1 recommendations (%) 78.9 (63.5 to 88.5) 94.2 (76.9 to 98.1) 0.03*
Possibility to implement all Grade 1A and 1B recommendations n (%) 27 (10.9) 3 (20) 0.28
Percentage of implementable Grade 1A and 1B recommendations (%) 87.5 (70.8 to 95.8) 95.8 (79.2 to 95.8) 0.09
Possibility to implement all Grade 1C and 1D recommendations n (%) 20 (8.1) 6 (40) <0.001*
Percentage of implementable Grade 1C and 1D recommendations (%) 71.4 (57.1 to 85.7) 92.9 (67.9 to 100) 0.02*
Possibility to implement all Grade 2 recommendations n (%) 3 (1.2) 1 (6.7) 0.09
Percentage of implementable Grade 2 recommendations (%) 52.4 (38.1 to 76.2) 81 (66.7 to 90.5) 0.009*
Possibility to implement all sepsis resuscitation bundles n (%) 36 (14.5) 7 (46.7) 0.001*
Bundle element “Lactate” n (%) 57 (23) 7 (46.7) 0.04*
Bundle element “Cultures” n (%) 176 (71) 12 (80) 0.45
Bundle element “Antibiotics” n (%) 189 (76.2) 15 (100) 0.03*
Bundle element “Hypotension” n (%) 225 (90.7) 13 (86.7) 0.6
Bundle element “CVP/ScvO2” n (%) 60 (24.2) 10 (66.7) <0.001*
Possibility to implement all sepsis management bundles n (%) 11 (4.4) 1 (6.7) 0.69
Bundle element “Steroids” n (%) 237 (95.6) 15 (100) 0.41
Bundle element “rhAPC” n (%) 13 (5.2) 2 (13.3) 0.19
Bundle element “Glucose” n (%) 208 (83.9) 13 (86.7) 0.77
Bundle element “Plateau Pressure” n (%) 172 (69.4) 10 (66.7) 0.83
SSC, Surviving Sepsis Campaign; *, significant group difference. Data are given as median values with interquartile ranges, if not otherwise indicated. The
Surviving Sepsis Campaign categorized their recommendations using the GRADE system which classifies recommendations as strong (grade 1) or weak (grade 2).
Furthermore, the system Classifies the quality of evidence as high (grade A), moderate (grade B), low (grade C), or very low (grade D).The grade of strong or
weak is considered of greater clinical importance than a difference in letter level of quality of evidence. Sepsis Resuscitation Bundles: Element “Lactate”,
measurement of serum lactate; Element “Cultures”, obtainment of blood cultures prior to antibiotic administration; Element “Antibiotics”, administration of broad-
spectrum antibiotics within three hours of emergency department admission and within one hour of non-emergency department admission; Element
“Hypotension”, treatment of hypotension and/or elevated lactate with fluids; Element “CVP/ScvO2”, maintenance of adequate central venous pressure and central
venous oxygen saturation. Sepsis Management Bundles: Element “Steroids”, administration of low-dose steroids for septic shock in accordance with a
standardized ICU policy; Element “rhAPC”, administration of recombinant human activated protein C in accordance with a standardized ICU policy; Element
“Glucose”, maintenance of blood glucose control lower limit of normal, but <180 mg/dL (10 mmol/L); Element “Plateau Pressure”, maintenance of a median
inspiratory plateau pressure <30 cmH2O for mechanically ventilated patients.
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Page 10 of 12￿ The Surviving Sepsis Campaign guidelines may not
be implementable by African, particularly not by
Sub-Saharan African, respondents due to a lack of
necessary resources.
￿ Availability of resources to implement the majority
of strong SSC recommendations (grade 1A and 1B)
may allow modification of current sepsis guidelines
based on available resources and implementation of
a substantial number of life-saving interventions into
sepsis care in Africa.
Additional material
Additional file 1: Electronic supplementary material. This file contains
the study questionnaire; a list of African nations eligible for participation
in this survey; hospital facilities, equipment, drugs and disposable
materials required to implement single recommendations/suggestions of
the Surviving Sepsis Campaign guidelines; and tables on differences
between Sub-Saharan African countries and South Africa/Mauritius/
Northern African countries.
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